Related Experiment Video
Updated: Apr 27, 2026
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Spontaneous complete remission of angioimmunoblastic T-cell lymphoma
Michael S Humeniuk1, Jackson J Liang1, Matthew Howard1
1Department of Medicine (Humeniuk, Liang), Division of Hematopathology (Howard), and Division of Hematology (Inwards), Mayo Clinic, Rochester, Minnesota.
Abstract:
Angioimmunoblastic T-cell lymphoma (AITL) is a rare hematologic neoplasm that typically presents with B symptoms, anemia, and lymphadenopathy. Its overall prognosis is poor, with a 5-year survival rate of 30%. We present a case of AITL that went into spontaneous remission, an uncommon occurrence.
More Related Videos
12:16A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023